A detailed history of Catalyst Funds Management Pty LTD transactions in Insmed Inc stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 11,250 shares of INSM stock, worth $911,925. This represents 0.19% of its overall portfolio holdings.

Number of Shares
11,250
Previous 7,000 60.71%
Holding current value
$911,925
Previous $511 Million 52.0%
% of portfolio
0.19%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$66.29 - $76.63 $281,732 - $325,677
4,250 Added 60.71%
11,250 $777 Million
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $434,000 - $553,070
7,000 New
7,000 $511 Million
Q1 2024

Dec 04, 2024

SELL
$25.72 - $29.94 $138,888 - $161,676
-5,400 Reduced 77.14%
1,600 $43.4 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $11B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.